134 related articles for article (PubMed ID: 32333927)
1. 12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy.
Dong C; Liu S; Cui Y; Guo Q
Eur J Pharmacol; 2020 Jul; 879():173122. PubMed ID: 32333927
[TBL] [Abstract][Full Text] [Related]
2. Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy.
Zhang YY; Wang WN; Su SS; Chen B; Sun WX; Wu H; Cheng YL; Xu ZG
Nephron; 2019; 142(1):61-70. PubMed ID: 30677774
[TBL] [Abstract][Full Text] [Related]
3. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.
Xu HZ; Cheng YL; Wang WN; Wu H; Zhang YY; Zang CS; Xu ZG
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164093
[TBL] [Abstract][Full Text] [Related]
4. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor.
Xu ZG; Yuan H; Lanting L; Li SL; Wang M; Shanmugam N; Kato M; Adler SG; Reddy MA; Natarajan R
J Am Soc Nephrol; 2008 Mar; 19(3):559-69. PubMed ID: 18235084
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R
Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
7. p16ink4a Expression Is Increased through 12-Lipoxygenase in High Glucose-Stimulated Glomerular Mesangial Cells and Type 2 Diabetic Glomeruli.
Zhang YY; Guo QY; Wu MY; Zang CS; Ma FZ; Sun T; Wang WN; Miao LN; Xu ZG
Nephron; 2015; 130(2):141-50. PubMed ID: 26022507
[TBL] [Abstract][Full Text] [Related]
8. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells.
Reddy MA; Adler SG; Kim YS; Lanting L; Rossi J; Kang SW; Nadler JL; Shahed A; Natarajan R
Am J Physiol Renal Physiol; 2002 Nov; 283(5):F985-94. PubMed ID: 12372774
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
[TBL] [Abstract][Full Text] [Related]
10. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects.
Reddy MA; Thimmalapura PR; Lanting L; Nadler JL; Fatima S; Natarajan R
J Biol Chem; 2002 Mar; 277(12):9920-8. PubMed ID: 11786549
[TBL] [Abstract][Full Text] [Related]
11. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
12. Role of histone modification in 12‑lipoxygenase‑associated p21 gene regulation.
Cui Y; Liu N; Ma F; Sun W; Wu H; Xu Z; Yuan H
Mol Med Rep; 2016 Oct; 14(4):3978-84. PubMed ID: 27600103
[TBL] [Abstract][Full Text] [Related]
13. A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease.
Antonipillai I; Nadler J; Vu EJ; Bughi S; Natarajan R; Horton R
J Clin Endocrinol Metab; 1996 May; 81(5):1940-5. PubMed ID: 8626861
[TBL] [Abstract][Full Text] [Related]
14. Evidence that 12-lipoxygenase product 12-hydroxyeicosatetraenoic acid activates p21-activated kinase.
Wen Y; Gu J; Knaus UG; Thomas L; Gonzales N; Nadler JL
Biochem J; 2000 Jul; 349(Pt 2):481-7. PubMed ID: 10880347
[TBL] [Abstract][Full Text] [Related]
15. Key Role of 12-Lipoxygenase and Its Metabolite 12-Hydroxyeicosatetraenoic Acid (12-HETE) in Diabetic Retinopathy.
Chen S; Zou H
Curr Eye Res; 2022 Mar; 47(3):329-335. PubMed ID: 35129022
[TBL] [Abstract][Full Text] [Related]
16. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.
Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R
J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821
[TBL] [Abstract][Full Text] [Related]
17. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy.
Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R
Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
[TBL] [Abstract][Full Text] [Related]
19. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice.
Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R
Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803
[TBL] [Abstract][Full Text] [Related]
20. 12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat.
Ma J; Natarajan R; LaPage J; Lanting L; Kim N; Becerra D; Clemmons B; Nast CC; Surya Prakash GK; Mandal M; Adler SG
Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):13-20. PubMed ID: 15589395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
